Glycopyrronium Bromide Rosemont Pharmaceuticals (Glycopyrronium Bromide)

Glycopyrronium bromide is prescribed for several respiratory and gastrointestinal conditions where reduction of smooth‑muscle tone or secretions is beneficial.

• Management of chronic obstructive pulmonary disease (COPD) to improve airflow.
• Adjunct therapy for asthma as a bronchodilator.
• Treatment of hyperhidrosis (excessive sweating) by decreasing glandular secretions.
• Supportive care in peptic ulcer disease to reduce gastric secretions.
• Off‑label use in certain bronchospastic disorders as determined by a physician.

The safety profile of glycopyrronium bromide includes both frequently observed and less common adverse events.

Common

• Dry mouth.
• Throat irritation.
• Constipation.
• Blurred vision.
• Urinary retention.

Serious

• Severe allergic reaction (anaphylaxis).
• Cardiac arrhythmias.
• Acute angle‑closure glaucoma.
• Persistent tachycardia.
• Respiratory depression (rare).

Before initiating therapy, clinicians should evaluate several precautionary factors to minimize risk.

• Assess for history of glaucoma, especially narrow‑angle type.
• Review urinary tract obstruction or prostate enlargement.
• Use cautiously in patients with cardiovascular disease or tachyarrhythmias.
• Monitor for signs of anticholinergic toxicity in the elderly.
• Avoid use during pregnancy or breastfeeding unless clearly indicated.
• Adjust dose in renal impairment as recommended by the prescriber.
• Counsel patients about potential dry‑mouth effects and hydration.

Glycopyrronium bromide may interact with other medications, altering its efficacy or safety.

Avoid

• Other anticholinergic agents (e.g., atropine, ipratropium) due to additive anticholinergic effects.
• Potent CYP3A4 inhibitors if the formulation involves metabolic pathways.

Use with caution

• Beta‑agonists (e.g., albuterol) – monitor for additive bronchodilation.
• Antihistamines – increased risk of dry mouth and urinary retention.
• Cardiac drugs such as digoxin – watch for altered heart rate.
• Drugs that lower intraocular pressure – may exacerbate glaucoma.